Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.45 USD | +1.37% | -6.32% | -32.78% |
Apr. 15 | TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR | CI |
Mar. 22 | Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.78% | 110M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- Transcript : TELA Bio, Inc., Q3 2023 Earnings Call, Nov 09, 2023